v3.26.3
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Class A common stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2024         83,267,367
Beginning balance at Dec. 31, 2024 $ 548.1 $ 699.6 $ (145.3) $ (6.2) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based awards vested and distributed (in shares)         943,902
Stock-based awards vested and distributed (1.2) (1.2)      
Director shares issued (in shares)         11,060
Amortization of restricted stock units 2.1 2.1      
Initial vesting of common stock warrants 6.0 6.0      
Provision for common stock warrants 0.8 0.8      
Net loss (10.9)   (10.9)    
Other comprehensive income (loss) (0.8)     (0.8)  
Ending balance (in shares) at Mar. 31, 2025         84,222,329
Ending balance at Mar. 31, 2025 544.1 707.3 (156.2) (7.0) $ 0.0
Beginning balance (in shares) at Dec. 31, 2024         83,267,367
Beginning balance at Dec. 31, 2024 548.1 699.6 (145.3) (6.2) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (28.8)        
Other comprehensive income (loss) (0.7)        
Ending balance (in shares) at Sep. 30, 2025         84,365,754
Ending balance at Sep. 30, 2025 537.8 718.8 (174.1) (6.9) $ 0.0
Beginning balance (in shares) at Mar. 31, 2025         84,222,329
Beginning balance at Mar. 31, 2025 544.1 707.3 (156.2) (7.0) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based awards vested and distributed (in shares)         3,500
Director shares issued (in shares)         120,190
Amortization of restricted stock units 2.0 2.0      
Provision for common stock warrants 1.0 1.0      
Net loss (7.5)   (7.5)    
Other comprehensive income (loss) (0.6)     (0.6)  
Ending balance (in shares) at Jun. 30, 2025         84,346,019
Ending balance at Jun. 30, 2025 539.0 710.3 (163.7) (7.6) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based awards vested and distributed (in shares)         4,198
Director shares issued (in shares)         15,537
Amortization of restricted stock units 2.1 2.1      
Initial vesting of common stock warrants 5.7 5.7      
Provision for common stock warrants 0.7 0.7      
Net loss (10.4)   (10.4)    
Other comprehensive income (loss) 0.7     0.7  
Ending balance (in shares) at Sep. 30, 2025         84,365,754
Ending balance at Sep. 30, 2025 $ 537.8 718.8 (174.1) (6.9) $ 0.0
Beginning balance (in shares) at Dec. 31, 2025 84,385,870       84,385,870
Beginning balance at Dec. 31, 2025 $ 534.9 722.3 (183.6) (3.8) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based awards vested and distributed (in shares)         1,133,298
Stock-based awards vested and distributed (0.7) (0.7)      
Director shares issued (in shares)         10,170
Amortization of restricted stock units 1.3 1.3      
Provision for common stock warrants 1.5 1.5      
Net loss (10.2)   (10.2)    
Other comprehensive income (loss) (2.3)     (2.3)  
Ending balance (in shares) at Mar. 31, 2026         85,529,338
Ending balance at Mar. 31, 2026 $ 524.5 724.4 (193.8) (6.1) $ 0.0
Beginning balance (in shares) at Dec. 31, 2025 84,385,870       84,385,870
Beginning balance at Dec. 31, 2025 $ 534.9 722.3 (183.6) (3.8) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25.3)        
Other comprehensive income (loss) $ (2.8)        
Ending balance (in shares) at Sep. 30, 2026 85,772,628       85,772,628
Ending balance at Sep. 30, 2026 $ 513.9 729.4 (208.9) (6.6) $ 0.0
Beginning balance (in shares) at Mar. 31, 2026         85,529,338
Beginning balance at Mar. 31, 2026 524.5 724.4 (193.8) (6.1) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Director shares issued (in shares)         220,812
Amortization of restricted stock units 1.2 1.2      
Provision for common stock warrants 1.5 1.5      
Net loss (7.9)   (7.9)    
Other comprehensive income (loss) 0.6     0.6  
Ending balance (in shares) at Jun. 30, 2026         85,750,150
Ending balance at Jun. 30, 2026 519.9 727.1 (201.7) (5.5) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based awards vested and distributed (in shares)         14,339
Director shares issued (in shares)         8,139
Amortization of restricted stock units 1.2 1.2      
Provision for common stock warrants 1.1 1.1      
Net loss (7.2)   (7.2)    
Other comprehensive income (loss) $ (1.1)     (1.1)  
Ending balance (in shares) at Sep. 30, 2026 85,772,628       85,772,628
Ending balance at Sep. 30, 2026 $ 513.9 $ 729.4 $ (208.9) $ (6.6) $ 0.0